A Bayesian change-point detection approach to the economic evaluation of risky projects: an application to healthcare technology assessment

Author:

Bregantini Daniele1,Schmitt Laetitia H M2,Thijssen Jacco J J3ORCID

Affiliation:

1. RTI Health Solutions , Manchester , UK

2. Clarivate , Milano , Italy

3. Department of Mathematics, University of York , York YO10 5DD , UK

Abstract

Abstract We propose a Bayesian hypothesis testing framework that allows for the assessment of evidence collected during a clinical trial about the cost-effectiveness of a healthcare technology. The model exploits a Bayesian updating rule that makes the link between the evidence collected in clinical research and the expected payoffs of adoption to the healthcare system. The framework takes into account the cost of decision errors in the payoff function, allowing the decision maker to compute the cost of taking a decision when evidence is far from the optimal decision triggers. We show, using a real-world cost-effectiveness study based on clinical trial evidence, how rules derived from a sequential adaptive design approach can lead to quicker decisions when compared to the value of information decision framework. Our application shows that a sequential approach has the potential to lead to quicker decisions, higher payoffs, and better health outcomes.

Publisher

Oxford University Press (OUP)

Subject

Statistics, Probability and Uncertainty,Economics and Econometrics,Social Sciences (miscellaneous),Statistics and Probability

Reference42 articles.

1. Expected value of sample information calculations in medical decision modelling;Ades;Medical Decision Making,2004

2. Investment in antiviral drugs: A real option approach;Attema;Health Economics,2010

3. One-sided sequential stopping boundaries for clinical trials: A decision-theoretic approach;Berry;Biometrics,1988

4. Real-world effectiveness of Omalizumab in severe allergic asthma: A meta-analysis of observational studies;Bousquet;The Journal of Allergy and Clinical Immunology: In Practice,2021

5. Cost-effectivness of Omalizumab in patients with severe persistent allergic asthma;Brown;Allergy,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3